You are here

Clinical Trials: Heart Attack

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Thursday, April 9, 2020 - 12:00
Condition:   Acute Myocardial Infarction
Intervention:   Biological: Mesenchymal Stem Cells
Sponsor:   PT. Prodia Stem Cell Indonesia
Posted: Tuesday, March 31, 2020 - 12:00
Condition:   Heart Attack
Intervention:   Drug: PEP in Acute Myocardial Infarction
Sponsor:   Paul G. Stalboerger
Not yet recruiting
Posted: Friday, March 13, 2020 - 12:00
Condition:   Critical Limb Ischemia
Interventions:   Drug: Evolocumab 140mg/mL Injector 1milliliter (mL) Pen x 3 for a monthly dose of 420 mg for 12 months.;   Other: Placebo 1 milliliter (mL) Injector Pen x 3 monthly for 12 months
Sponsors:   Leonardo Clavijo;   Amgen
Posted: Wednesday, August 14, 2019 - 12:00
Condition:   Acute Myocardial Infarction
Intervention:   Biological: Allogeneic umbilical cord mesenchymal stem cells
Sponsor:   Ever Supreme Bio Technology Co., Ltd.
Posted: Thursday, August 8, 2019 - 12:00
Condition:   Myocardial Infarction
Intervention:   Biological: MiSaver®
Sponsors:   Honya Medical Inc;   Chung Shan Medical University
Posted: Thursday, May 16, 2019 - 12:00
Condition:   Coronary Artery Disease
Interventions:   Combination Product: PCI with BioMatrix Alpha™ stent;   Combination Product: PCI with Combo™ stent
Sponsors:   Phillip Freeman;   Aarhus University Hospital;   Odense University Hospital;   OrbusNeich;   Biosensors International
Not yet recruiting
Posted: Wednesday, April 3, 2019 - 12:00
Conditions:   Left Ventricular Dysfunction;   Acute Myocardial Infarction
Interventions:   Biological: UC-MSC;   Biological: Control Group
Sponsors:   Shanghai Life Science & Technology;   Shanghai Jiao Tong University Affiliated Sixth People’s Hospital
Not yet recruiting
Posted: Wednesday, January 9, 2019 - 12:00
Condition:   Myocardial Infarction
Interventions:   Combination Product: PeriCord: Expanded and cryopreserved allogeneic umbilical cord Wharton´s jelly-derived adult mesenchymal stem cells colonized on human pericardial matrix.;   Procedure: Surgery by sternotomy
Sponsors:   Fundació Institut Germans Trias i Pujol;   Germans Trias i Pujol Hospital
Not yet recruiting
Posted: Monday, December 3, 2018 - 12:00
Conditions:   Diabetes Mellitus, Type 2;   Coronary Artery Disease
Interventions:   Dietary Supplement: Trans-resveratrol;   Dietary Supplement: Placebo
Sponsors:   Maine Medical Center;   American Heart Association
Posted: Tuesday, May 15, 2018 - 12:00
Condition:   HLHS
Intervention:   Biological: Longeveron Mesenchymal Stem Cells
Sponsor:   Longeveron LLC